Reports Library Publication
Cough, Cold & Allergy: Unravelling CCA Opportunities in a Post-Pandemic World
31st July 2025 by Nicholas Hall Reports
Cough, Cold & Allergy was the slowest-growing CHC category globally in 2024, as systemic cold & flu and cough remedies progressed at a modest rate, but the outlook is steady, with growth trends returning to a more normal level. While demand for many products is dependent on incidence and severity of seasonal pathologies, marketers are identifying new niches to drive year-round sales such as high levels of air pollution.
This report will investigate pressing issues affecting the global CCA market, digging into multiple areas of interest and highlighting inherent opportunities. Examining ten core markets in detail (and additional key markets in brief), analysing brand performances and launch activity, our CCA report will investigate the untapped potential in this CHC category.
Order this report
Diving into the factors affecting individual Cough, Cold & Allergy markets, from consumer trends and regulatory changes to A+P campaigns and new product launch activity, this report sheds light on trends & developments across 10 in-depth country profiles with insights and predictions, as well as shorter profiles of other key markets.
Why buy this report?
"The report features the latest end-2024 sales data from our dedicated DB6 database, including topline historical sales globally, by country and category, as well as individual brand performances, and long-term forecasts to 2029 and 2034. Coverage extends to the online channel, with internet & mail order sales of CCA included in the topline and a dedicated section in each country profile."
Nicholas Hall